Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Fishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Vatiquinone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 1213269-98-7, Epi-743, Alpha-tocotrienol quinone, Epi 743, Alpha tocotrienol quinone, .alpha.-tocotrienol quinone
    Molecular Formula
    C29H44O3
    Molecular Weight
    440.7  g/mol
    InChI Key
    LNOVHERIIMJMDG-XZXLULOTSA-N
    FDA UNII
    6O85FK9I0X
    Vatiquinone has been investigated for the treatment and prevention of Retinopathy, Rett Syndrome, Genetic Disease, Noise-induced Hearing Loss, and Methylmalonic Aciduria and Homocystinuria,Cblc Type.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    2-[(3R,6E,10E)-3-hydroxy-3,7,11,15-tetramethylhexadeca-6,10,14-trienyl]-3,5,6-trimethylcyclohexa-2,5-diene-1,4-dione
    2.1.2 InChI
    InChI=1S/C29H44O3/c1-20(2)12-9-13-21(3)14-10-15-22(4)16-11-18-29(8,32)19-17-26-25(7)27(30)23(5)24(6)28(26)31/h12,14,16,32H,9-11,13,15,17-19H2,1-8H3/b21-14+,22-16+/t29-/m1/s1
    2.1.3 InChI Key
    LNOVHERIIMJMDG-XZXLULOTSA-N
    2.1.4 Canonical SMILES
    CC1=C(C(=O)C(=C(C1=O)C)CCC(C)(CCC=C(C)CCC=C(C)CCC=C(C)C)O)C
    2.1.5 Isomeric SMILES
    CC1=C(C(=O)C(=C(C1=O)C)CC[C@@](C)(CC/C=C(\C)/CC/C=C(\C)/CCC=C(C)C)O)C
    2.2 Other Identifiers
    2.2.1 UNII
    6O85FK9I0X
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Alpha-tocotrienol Quinone

    2. Epi-743

    2.3.2 Depositor-Supplied Synonyms

    1. 1213269-98-7

    2. Epi-743

    3. Alpha-tocotrienol Quinone

    4. Epi 743

    5. Alpha Tocotrienol Quinone

    6. .alpha.-tocotrienol Quinone

    7. 6o85fk9i0x

    8. 2,5-cyclohexadiene-1,4-dione, 2-((3r,6e,10e)-3-hydroxy-3,7,11,15-tetramethyl-6,10,14-hexadecatrien-1-yl)-3,5,6-trimethyl-

    9. 2-((r,6e,10e)-3-hydroxy-3,7,11,15-tetramethylhexadeca-6,10,14-trien-1-yl)-3,5,6-trimethylcyclohexa-2,5-diene-1,4-dione

    10. Vatiquinone [usan]

    11. Vatiquinone [usan:inn]

    12. Unii-6o85fk9i0x

    13. Vatiquinone [inn]

    14. Vatiquinone [jan]

    15. Vatiquinone (jan/usan)

    16. Schembl503125

    17. (r)-alpha-tocotrienol Quinone

    18. Chembl1812161

    19. Schembl14639355

    20. Dtxsid90153231

    21. Bcp21072

    22. Ex-a5566

    23. Db11917

    24. 2-[(3r,6e,10e)-3-hydroxy-3,7,11,15-tetramethylhexadeca-6,10,14-trienyl]-3,5,6-trimethylcyclohexa-2,5-diene-1,4-dione

    25. Hy-16772

    26. Cs-0012384

    27. D10407

    28. A937320

    29. Q27265220

    30. Epi 743;epi743; Vatiquinone; Alpha-tocotrienol Quinone

    31. 2-((3r,6e,10e)-3-hydroxy-3,7,11,15-tetramethylhexadeca-6,10,14-trien-1-yl)-3,5,6-trimethylcyclohexa-2,5-diene-1,4-dione

    32. 2-[(3r,6e,10e)-3-hydroxy-3,7,11,15-tetramethyl-6,10,14-hexadecatrien-1-yl]-3,5,6-trimethyl-2,5-cyclohexadiene-1,4-dion

    2.4 Create Date
    2010-07-06
    3 Chemical and Physical Properties
    Molecular Weight 440.7 g/mol
    Molecular Formula C29H44O3
    XLogP37.4
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count3
    Rotatable Bond Count12
    Exact Mass440.32904526 g/mol
    Monoisotopic Mass440.32904526 g/mol
    Topological Polar Surface Area54.4 Ų
    Heavy Atom Count32
    Formal Charge0
    Complexity857
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count2
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Treatment of Leigh syndrome

    Treatment of mitochondrial disease